GC
BSX icon

GMT Capital’s Boston Scientific BSX Stock Holding History

GMT Capital’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.76M Buy
+64,600
New +$3.51M 0.14% 37

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

GMT Capital's BSX Position: Q2 2026 in Review

GMT Capital opened a new position in Boston Scientific (BSX) in Q2 2026: 64,600 shares worth $2.76M. The stake represents 0.14% of the portfolio and ranks #37 among its holdings.

1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • GMT Capital held 64,600 shares of Boston Scientific worth $2.76M as of Q2 2026.
  • Boston Scientific was a new GMT Capital position in Q2 2026.
  • Boston Scientific made up 0.14% of GMT Capital's portfolio in Q2 2026, its #37 holding.
  • 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on GMT Capital's 13F filing for Q2 2026, filed 14 Aug 2026.